Multimodal clinical imaging assessment of the outcome in mild-to-moderate acne: A prospective study
Dermatology Aug 11, 2019
Kyrgidis A, et al. - In this prospective, monocentric, single-group open study involving 49 patients (mean age was 18.2 ± 3.7 years), researchers assessed the application of multimodal clinical imaging (MCI), a combination of imaging technology and computation, in the evaluation of acne lesions in a clinical study setting. They assessed the effectiveness and tolerance of a cosmetic product in individuals with mild-to-moderate facial acne by classical clinical counting (CCC) – change in the total/inflammatory/noninflammatory acne lesion number vs baseline (D0) – Investigator Global Assessment and self-reported outcomes. Data reported that the mean acne duration was 3.8 ± 2.8 years. Findings revealed that MCI, first applied in a small clinical study setting, is at least as reliable as CCC and can enable a sensitive longitudinal evaluation of single acne lesions and their response to products, particularly in conditions where clinical evaluation reaches its limitations.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries